IPO · BON
Bon Natural Life Ltd
Bon Natural Life Ltd (BON) priced its initial public offering on Jun 25, 2021 at $5.00 per share, raising $11M, and listed on Nasdaq Capital Market. At the IPO price its market capitalization was about $40M. US Tiger was lead-left underwriter, joined by Newbridge and R.F. Lafferty. Crone Law Group, Ogier and Chamzon Law Firm advised the company and Ellenoff Grossman & Schole and Beijing DeHeng Law Office advised the underwriters.
Bon Natural Life Ltd manufactures personal care ingredients, such as plant-extracted fragrance compounds, along with natural health supplements and bioactive food ingredients used in additives and nutritional supplements. It supplies third-party customers in the functional food, personal care and natural medicine industries and sells under its own brands.
- Status
- IPO
- Ticker
- BON
- Exchange
- Nasdaq Capital Market
- Priced
- Jun 25, 2021
- IPO price
- $5.00
- Raised
- $11M
- Market cap at IPO price
- $40M
- First filed
- Dec 7, 2020
- Underwriters
- US Tiger, Newbridge and R.F. Lafferty
- Company counsel
- Crone Law Group, Ogier and Chamzon Law Firm
- Underwriters' counsel
- Ellenoff Grossman & Schole and Beijing DeHeng Law Office
- Sector
- Biotech & pharma
- Country / state
- China
Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.
More on this listing for subscribers
- Lock-up period and expiry date
- Shares offered, over-allotment and shares outstanding after the offering
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (F-1) first filed Dec 7, 2020
- Latest amendment Jun 22, 2021
- Final prospectus (424B4) Jun 25, 2021
- All filings on EDGAR CIK 1816815
Other Biotech & pharma IPOs in 2021
- Acurx Pharmaceuticals, Inc.ACXP · Jun 28, 2021
- GH Research PLCGHRS · Jun 28, 2021
- Elevation Oncology, Inc.ELEV · Jun 25, 2021
- Alpha Teknova, Inc.TKNO · Jun 25, 2021 · $96M
- Monte Rosa Therapeutics, Inc.GLUE · Jun 25, 2021 · $222.3M
- Miromatrix Medical Inc.MIRO · Jun 24, 2021 · $43.2M